Letters
Ramifications of screening for breast cancer: Definition of overdiagnosis is confusing in follow-up of Malmö trial
BMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7543.727-b (Published 23 March 2006) Cite this as: BMJ 2006;332:727
- Per-Henrik Zahl, senior statistician (per-henrik.zahl@fhi.no),
- Jan Mæhlen, professor
- Norwegian Institute of Public Health, PO Box 4404 Nydalen, N-0403, Oslo, Norway
- Department of Pathology, Ullevål University Hospital, N-0407 Oslo
EDITOR—In their follow-up of the Malmö mammography trial, Zackrisson et al say that the reported levels of overdiagnosis vary from 5% to 50%.1 However, to use cumulative incidence rates at the end of follow-up to quantify the level of overdiagnosis is confusing because the resulting estimates are highly sensitive to both the length of follow-up and the length of …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.